BB50245: Advances in molecular medicine
![]() | 2019/0 |
![]() | Department of Biology & Biochemistry |
![]() | 20 [equivalent to 40 CATS credits] |
![]() | 400 |
![]() | Masters UG & PG (FHEQ level 7) |
![]() |
|
![]() | CW 50%, EX-TH 40%, OT 10%* |
![]() |
*Assessment updated due to Covid-19 disruptions |
![]() |
|
![]() | |
![]() | Aims: The unit is aimed at synthesising and advancing our knowledge of how molecular, cellular and genetic / epigenetic processes regulate human health and disease. Learning Outcomes: By the end of this unit you will be able to: * Apply your understanding of your core molecular medicine knowledge drawing on concepts in the molecular and cellular basis of disease * Critically evaluate and communicate the findings of a cutting-edge molecular medicine research publication through a formal presentation * Critically evaluate, synthesise and summarise the findings of a variety of cutting-edge molecular medicine research publications through a written literature review * Demonstrate an integrative and evaluative approach to addressing some of the challenges and opportunities in treating human diseases. Content: This unit is aimed at synthesising and advancing our knowledge of how molecular, cellular and genetic / epigenetic processes regulate human health and disease. Topics will include: * molecular genetics/epigenetics of cancer, diabetes, stem cell reprogramming, medical neuroscience, immunology and epidemiology of infections. * Molecular approaches used to develop interventions (genomics for vaccine and chemotherapeutic target identification, Next Generation Sequencing, epidemiology and prediction, regenerative medicine, personalised medicine). |
![]() |
BB50245 is a Designated Essential Unit on the following programmes:Department of Biology & Biochemistry
|
Notes:
|